HRS-7535 Tablets
Sponsors
Shandong Suncadia Medicine Co., Ltd.
Conditions
DiabetesObesityOverweightType 2 DiabetesType 2 Diabetes Mellitus
Phase 1
Pharmacokinetic and Safety Studies of HRS-7535 in Subjects With Moderate Renal Insufficiency and Healthy Subjects
CompletedNCT06132204
Start: 2023-12-21End: 2024-03-13Updated: 2024-10-15
Study on Drug Interaction of HRS-1780 Tablets, Henagliflozin Tablets, Metformin Tablets and HRS-7535 Tablets in Healthy Human
Not yet recruitingNCT06495931
Start: 2024-07-31End: 2024-07-31Target: 24Updated: 2024-07-11
Study on Drug Interaction of Metformin Tablets and HRS-7535 Tablets in Healthy Human
Not yet recruitingNCT06727838
Start: 2024-12-31End: 2025-05-31Target: 54Updated: 2024-12-11
A Study to Evaluate the Drug Interactions of HRS-7535 With Acetaminophen, Digoxin, Rosuvastatin, and Omeprazole in Obese or Overweight Subjects
RecruitingNCT07269756
Start: 2025-12-08End: 2026-02-28Target: 40Updated: 2025-12-31